Menu Back toSESSION-2-PANEL-DISCUSSION

4th DIA Cell and Gene Therapy Products Symposium in Japan

All prices are exclusive of 10% Japanese consumption tax

SESSION 2 - PANEL DISCUSSION

Session Chair(s)

Keiji  Miyamoto

Keiji Miyamoto

  • Principle, Regulatory Affairs Group, Post-Marketing Regulatory Affairs Dept.
  • Daiichi Sankyo Co., Ltd., Japan
Daisaku  Sato, PhD, MPharm, RPh

Daisaku Sato, PhD, MPharm, RPh

  • Director, Compliance & Narcotics Division
  • Ministry of Health, Labour and Welfare, Japan

Contact us


Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574